JCVIX
Price
$21.56
Change
-$0.15 (-0.69%)
Updated
Jul 22 closing price
Net Assets
530.78M
JVMSX
Price
$30.53
Change
-$0.03 (-0.10%)
Updated
Jul 23 closing price
Net Assets
23.26B
Interact to see
Advertisement

JCVIX vs JVMSX

JCVIX vs JVMSX Comparison Chart in %
View a ticker or compare two or three
VS
JCVIX vs. JVMSX commentary
Jul 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCVIX is a Buy and JVMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 23.3B vs. JCVIX (531M). JCVIX pays higher dividends than JVMSX: JCVIX (1.99) vs JVMSX (0.35). JCVIX was incepted earlier than JVMSX: JCVIX (24 years) vs JVMSX (14 years). JVMSX (1.25) is less costly to investors than JCVIX (0.87). JVMSX is a more actively managed with annual turnover of: 48.00 vs. JCVIX (13.00). JVMSX has a lower initial minimum investment than JCVIX: JVMSX (0) vs JCVIX (250000). JVMSX annual gain was more profitable for investors over the last year : 5.35 vs. JCVIX (-12.30). JVMSX return over 5 years is better than : 12.69 vs. JCVIX (-37.27).
JCVIXJVMSXJCVIX / JVMSX
Total Expense Ratio0.861.2469%
Annual Report Gross Expense Ratio0.871.2570%
Fund Existence24 years14 years-
Gain YTD11.50511.71798%
Front LoadN/AN/A-
Min. Initial Investment2500000-
Min. Initial Investment IRAN/AN/A-
Net Assets531M23.3B2%
Annual Yield % from dividends1.990.35569%
Returns for 1 year-12.305.35-230%
Returns for 3 years-34.8215.14-230%
Returns for 5 years-37.2712.69-294%
Returns for 10 years-1.9453.21-4%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DINIX26.260.07
+0.27%
BNY Mellon International Stock Index I
BTMPX21.110.02
+0.09%
iShares MSCI EAFE Intl Idx Inv P
DLCIX22.98N/A
N/A
Dana Large Cap Equity Institutional
RIVGX21.46N/A
N/A
American Funds Intl Vntg R-6
PXSIX22.76-0.31
-1.34%
Impax Small Cap Institutional